BANK OF AMERICA CORP /DE/ - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q4 2022$1840
-75.5%
0.00%
Q3 2022$0163
+1.2%
0.00%
Q2 2022$0
-100.0%
161
-99.6%
0.00%
Q1 2022$52,000
-73.1%
36,958
-23.0%
0.00%
Q4 2021$193,000
-52.8%
48,023
-26.6%
0.00%
Q3 2021$409,000
+77.8%
65,394
+214.5%
0.00%
Q2 2021$230,000
-51.1%
20,795
-43.1%
0.00%
Q1 2021$470,00036,5570.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,073,1760.05%
WELLS FARGO & COMPANY/MN 174$840.00%
NORTHERN TRUST CORP 27,860$13,3730.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 140,530$67,4540.00%
STATE STREET CORP 47,436$22,7690.00%
MILLENNIUM MANAGEMENT LLC 91,463$43,9020.00%
DEUTSCHE BANK AG\ 45,294$21,7410.00%
MORGAN STANLEY 61,857$29,6910.00%
BlackRock Inc. 76,307$36,6280.00%
View complete list of TALIS BIOMEDICAL CORP shareholders